NCT00048360 - Attention-Deficit Hyperactivity Disorder (ADHD) Study With Adults | Biotech Hunter

Enrollment

162

Participants

Timeline

Start Date

October 31, 2002

Primary Completion Date

June 30, 2003

Study Completion Date

June 30, 2003

Conditions

Attention Deficit Disorder

Interventions

DRUG

Extended-release bupropion hydrochloride

Trial Locations (21)

20852

GSK Clinical Trials Call Center, Rockville

27514

GSK Clinical Trials Call Center, Chapel Hill

33407

GSK Clinical Trials Call Center, West Palm Beach

42003

GSK Clinical Trials Call Center, Paducah

44122

GSK Clinical Trials Call Center, Beachwood

68105

GSK Clinical Trials Call Center, Omaha

77007

GSK Clinical Trials Call Center, Houston

77401

GSK Clinical Trials Call Center, Bellaire

84132

GSK Clinical Trials Call Center, Salt Lake City

85016

GSK Clinical Trials Call Center, Phoenix

91324

GSK Clinical Trials Call Center, Northridge

91910

GSK Clinical Trials Call Center, Chula Vista

91978

GSK Clinical Trials Call Center, Spring Valley

94549

GSK Clinical Trials Call Center, Lafayette

97209

GSK Clinical Trials Call Center, Portland

98104

GSK Clinical Trials Call Center, Seattle

02138

GSK Clinical Trials Call Center, Cambridge

01655

GSK Clinical Trials Call Center, Worcester

45267-0559

GSK Clinical Trials Call Center, Cincinnati

05405

GSK Clinical Trials Call Center, Burlington

05091

GSK Clinical Trials Call Center, Woodstock